Clinical trial
The Effect of Gum Arabic (GA) on Adult Dialysis Patients in Abu Dhabi: A Prospective Randomized-controlled Trial (The GADAD Study)
NCT06836206 is registered in ClinicalTrials.gov with Abu Dhabi Health Services Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Gum Arabic (GA) on Adult Dialysis Patients in Abu Dhabi: A Prospective Randomized-controlled Trial (The GADAD Study)
- Lead sponsor
- Abu Dhabi Health Services Company
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- February 3, 2025
- Completion date
- April 30, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease (esrd)